Imugene (IMU.AX) Earnings Analysis

Imugene (IMU.AX) next reports earnings on 2026-09-02, consensus EPS -0.03625 AUD. Last quarter (2025-02-27) it beat with EPS -0.00653 AUD vs -0.01 AUD est (+34.7%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -0.41.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IMU.AX next report earnings?

Next earnings date2026-09-02
Consensus EPS estimate-0.03625 AUD
Revenue estimate0.00B

IMU.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-02-27-0.00653 AUD-0.01 AUD+34.7%Beat
2024-10-31-0.0111 AUD-0.01 AUD-11%Miss

Beat rate: 1/2 (50%) over reported quarters with consensus data.

IMU.AX valuation and analyst view

Trailing P/E-0.41
Trailing EPS-0.20048 AUD
Price / book0.64
Dividend yield0.00%
Market cap0.04B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Imugene (IMU.AX)'s next earnings date?

Imugene is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.03625 AUD and revenue estimate of 0.00B.

Did IMU.AX beat earnings last quarter?

In its 2025-02-27 report, IMU.AX posted EPS of -0.00653 AUD versus a -0.01 AUD estimate — a beat of 34.7%.

What is IMU.AX's earnings track record?

Over the last 2 reported quarters with consensus data, IMU.AX beat estimates 1 times (50%).

What is IMU.AX's current P/E ratio and EPS?

IMU.AX trades at a trailing P/E of -0.41 on trailing EPS of -0.20047590010608066 AUD.

What do analysts rate IMU.AX?

IMU.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.